Literature DB >> 16940453

Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities.

Marie-Laure Sobrier1, Mohamad Maghnie, Marie-Pierre Vié-Luton, Andrea Secco, Natascia di Iorgi, Renata Lorini, Serge Amselem.   

Abstract

CONTEXT: Hesx1 is one of the earliest homeodomain transcription factors expressed during pituitary development. Very few HESX1 mutations have been identified in humans; although in those cases the disease phenotype shows considerable variability, all but one of the patients display an ectopic posterior pituitary and/or optic nerve abnormalities.
OBJECTIVE: The objectives of the study were to describe the complex phenotype associated with the panhypopituitarism of two unrelated Italian patients who, at birth, presented with hypoglycemic seizures and respiratory distress complicated by shock, in a familial context of neonatal death in one family and spontaneous miscarriage in both families and to identify the molecular basis of this unusual syndrome. MAIN OUTCOME MEASURES: Magnetic resonance imaging of the pituitary region, study of HESX1 gene and transcripts, and assessment of the ability of mutated HESX1 proteins to repress transcription were measured.
RESULTS: Magnetic resonance imaging examination showed an anterior pituitary aplasia in a flat sella turcica and a normally located posterior pituitary in both patients. A constellation of extrapituitary developmental defects were found in the two patients, but without any optic nerve abnormalities. Sequencing of HESX1 exons and their flanking intronic regions revealed two different homozygous mutations. A frameshift (c.449_450delAC) was identified in one case, whereas the other patient carried a splice defect (c.357 + 2Tb > C) confirmed by the study of HESX1 transcripts. If translated, these mutations would lead to the synthesis of truncated proteins partly or entirely lacking the homeodomain, with no transcriptional repression, as shown by their inability to inhibit PROP1 activity.
CONCLUSIONS: These observations reveal two novel HESX1 mutations in a so-far-undescribed disease phenotype characterized by a life-threatening neonatal condition associated with anterior pituitary aplasia, in the absence of ectopic posterior pituitary and optic nerve abnormalities, two features classically associated with HESX1 defects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940453     DOI: 10.1210/jc.2006-0426

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

Review 1.  Septo-optic dysplasia.

Authors:  Emma A Webb; Mehul T Dattani
Journal:  Eur J Hum Genet       Date:  2009-07-22       Impact factor: 4.246

Review 2.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

3.  HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype.

Authors:  Qing Fang; Anna Flavia Figueredo Benedetti; Qianyi Ma; Louise Gregory; Jun Z Li; Mehul Dattani; Abdollah Sadeghi-Nejad; Ivo J P Arnhold; Berenice Bilharinho Mendonca; Sally A Camper; Luciani R Carvalho
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-28       Impact factor: 3.478

Review 4.  The origins of the circumventricular organs.

Authors:  Clemens Kiecker
Journal:  J Anat       Date:  2017-12-27       Impact factor: 2.610

5.  A novel SNP of the Hesx1 gene in bovine and its associations with average daily gain.

Authors:  Xinsheng Lai; Xianyong Lan; Hong Chen; Xinlei Wang; Keyi Wang; Mou Wang; Hui Yu; Miao Zhao
Journal:  Mol Biol Rep       Date:  2008-10-14       Impact factor: 2.316

6.  Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.

Authors:  G Corneli; D Vivenza; F Prodam; G Di Dio; A Vottero; A Rapa; S Bellone; S Bernasconi; G Bona
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

7.  Unusual phenotypic features in a patient with a novel splice mutation in the GHRHR gene.

Authors:  Latifa Hilal; Yassir Hajaji; Marie-Pierre Vie-Luton; Zeina Ajaltouni; Bouchra Benazzouz; Maha Chana; Adelmajid Chraïbi; Abdelkrim Kadiri; Serge Amselem; Marie-Laure Sobrier
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

8.  Effects of genetic variability of the caprine homeobox transcription factor HESX1 gene on performance traits.

Authors:  Xianyong Lan; Xinsheng Lai; Zhuanjian Li; Jing Wang; Chuzhao Lei; Hong Chen
Journal:  Mol Biol Rep       Date:  2009-07-23       Impact factor: 2.316

Review 9.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

10.  Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism.

Authors:  Ezat Sajedi; Carles Gaston-Massuet; Massimo Signore; Cynthia L Andoniadou; Daniel Kelberman; Sandra Castro; Heather C Etchevers; Dianne Gerrelli; Mehul T Dattani; Juan Pedro Martinez-Barbera
Journal:  Dis Model Mech       Date:  2008-11-06       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.